VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company...
Discover how modern moms are integrating mushrooms into their lifestyles, and how it impacts their parenting. Dive into experiences, benefits, and cha...
Alberta Blue Cross’s recent decision to include psychedelic-assisted therapy in their healthcare coverage marks a transformative moment in the perception...
Toronto, Ontario–(Newsfile Corp. – April 4, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the...
VANCOUVER, BC, April 3, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage...
MORRISTOWN, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to...
In an unexpected turn of events, Compass Pathways plc (Nasdaq: CMPS), a leading figure in the mental health sector, witnessed a notable dip in its stock...
OTTAWA, April 02, 2024 (GLOBE NEWSWIRE) — PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine industry, welcomes...
LONDON, April 01, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
NEW YORK and BERLIN, March 28, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”) a clinical-stage biopharmaceutical...